Literature DB >> 17394217

Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis.

S Reisine1, J Fifield, S Walsh, D Dauser.   

Abstract

OBJECTIVE: To analyze factors associated with leaving employment among women with newly diagnosed rheumatoid arthritis (RA).
METHODS: Women with RA were recruited from a national sample of rheumatologists in 1987 and 1998. Inclusion criteria were RA diagnosis <18 months earlier, age >or=18 years, and no other disabling health condition. The 1987 and 1998 cohorts comprised 48 and 91 women, respectively. Data were collected by telephone for 4 years. Survival analysis was conducted using Kaplan-Meier curves and a proportional hazards generalized linear model to assess whether the time to stopping work differed between the cohorts and to identify baseline predictors and time-varying covariates of leaving work.
RESULTS: Most patients were age <50 years, married, had >12 years of education, and were white. Fifteen patients (31%) in the 1987 cohort and 24 patients (26%) in the 1998 cohort stopped working in the observation periods. Kaplan-Meier survival curves for each cohort were not significantly different. Multivariate analyses demonstrated that married women (P = 0.03) and those with joint deformities (P = 0.00) were more likely to stop working. A significant flares by cohort interaction (P = 0.01) indicated that, in comparison with patients in the 1998 cohort, those in the 1987 cohort with <2 disease flares had the lowest risk of stopping work and those with >or=2 flares had the greatest risk.
CONCLUSION: Unexpectedly, the cumulative rate of stopping work among women in the 1998 study did not differ from that among women diagnosed >16 years earlier. However, disease flares greatly affected employment in the 1987 but not the 1998 cohort, possibly indicating that newer medications were effective in maintaining functional status among those with more severe disease activity, measured by number of flares, in the 1998 group.

Entities:  

Mesh:

Year:  2007        PMID: 17394217      PMCID: PMC1853369          DOI: 10.1002/art.22620

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  41 in total

1.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

Review 2.  Markers for work disability in rheumatoid arthritis.

Authors:  T Sokka; T Pincus
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

3.  The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.

Authors:  E M Barrett; D G Scott; N J Wiles; D P Symmons
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

4.  Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study.

Authors:  J Jäntti; K Aho; K Kaarela; H Kautiainen
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

Review 5.  Update on work disability in rheumatic diseases.

Authors:  S H Allaire
Journal:  Curr Opin Rheumatol       Date:  2001-03       Impact factor: 5.006

6.  Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

Authors:  S Merkesdal; J Ruof; O Schöffski; K Bernitt; H Zeidler; W Mau
Journal:  Arthritis Rheum       Date:  2001-03

7.  Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).

Authors:  A Young; J Dixey; E Kulinskaya; N Cox; P Davies; J Devlin; P Emery; A Gough; D James; P Prouse; P Williams; J Winfield
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

8.  Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.

Authors:  Kari Puolakka; Hannu Kautiainen; Timo Möttönen; Pekka Hannonen; Markku Korpela; Heikki Julkunen; Reijo Luukkainen; Kaisa Vuori; Leena Paimela; Harri Blåfield; Markku Hakala; Marjatta Leirisalo-Repo
Journal:  Arthritis Rheum       Date:  2004-01

Review 9.  Employment and work disability in rheumatoid arthritis.

Authors:  Catherine L Backman
Journal:  Curr Opin Rheumatol       Date:  2004-03       Impact factor: 5.006

10.  Association between etanercept use and employment outcomes among patients with rheumatoid arthritis.

Authors:  Edward Yelin; Laura Trupin; Patricia Katz; Deborah Lubeck; Stephanie Rush; Lee Wanke
Journal:  Arthritis Rheum       Date:  2003-11
View more
  4 in total

Review 1.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

2.  A cost-utility analysis of nonsurgical management, total wrist arthroplasty, and total wrist arthrodesis in rheumatoid arthritis.

Authors:  Christi M Cavaliere; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2010-03       Impact factor: 2.230

3.  Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Michael P Lavalley
Journal:  Arthritis Rheum       Date:  2008-04-15

4.  Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort.

Authors:  Saralynn Allaire; Frederick Wolfe; Jingbo Niu; Michael P LaValley; Bin Zhang; Susan Reisine
Journal:  Arthritis Rheum       Date:  2009-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.